Royal Bank of Canada »

Belite Bio shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $360k 2.3k 159.63
2024-12-31 $0 5 0.00

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Belite Bio

Darwin Global Management
Paradigm Biocapital Advisors
UBS Group
Rtw Investments
Millennium Management
Holocene Advisors
Eventide Asset Management
Deerfield Management Company
Morgan Stanley
Marshall Wace
Perceptive Advisors
Patient Square Capital
Duquesne Family Office
Goldman Sachs Group
MPM Oncology Impact Management

View all funds holding Belite Bio